Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × poly ICLC × Clear all

Sponsor

Conditions

Melanoma 6 Glioma 4 Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Metastatic Castration-resistant Prostate Cancer 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Gliosarcoma 1

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Dactinomycin 5 temsirolimus 4 cixutumumab 4 Sirolimus 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 X-Rays 3 Radiation 3 Phantoms, Imaging 3 Doxorubicin 3 thymoglobulin 2 fludarabine phosphate 2 eribulin 2 Vinorelbine 2 Temozolomide 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Image-Guided 2 Peripheral Blood Stem Cell Transplantation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Melphalan 2 Ifosfamide 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡